HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Y Terashima Selected Research
Y Terashima Research Topics
Disease
4
Neoplasms (Cancer)
09/2013 - 01/2000
3
Inflammation (Inflammations)
02/2022 - 06/2001
3
Pain (Aches)
05/2016 - 09/2000
3
Body Weight (Weight, Body)
04/2006 - 05/2002
2
Radiculopathy (Radiculopathy, Cervical)
05/2016 - 09/2012
2
Neoplasm Metastasis (Metastasis)
09/2013 - 09/2000
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2001 - 01/2000
1
Rheumatoid Arthritis
09/2019
1
Necrosis
09/2019
1
Neuralgia (Stump Neuralgia)
05/2016
1
Type 2 Diabetes Mellitus (MODY)
06/2014
1
Adenocarcinoma of Lung
09/2013
1
Carcinogenesis
09/2013
1
Hyperalgesia
09/2012
1
Diabetes Mellitus
05/2009
1
Arteriosclerosis
05/2009
1
Cardiovascular Diseases (Cardiovascular Disease)
05/2009
1
Acquired Immunodeficiency Syndrome (AIDS)
02/2007
1
Insulin Resistance
04/2006
1
Weight Gain
07/2004
1
Chronic Hepatitis B
06/2001
1
Adenocarcinoma
01/2001
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2001
1
Breast Neoplasms (Breast Cancer)
01/2001
1
Ovarian Neoplasms (Ovarian Cancer)
12/2000
1
Ovarian Epithelial Carcinoma
12/2000
1
Hypersensitivity (Allergy)
12/2000
1
Edema (Dropsy)
12/2000
1
Hypercalcemia (Milk Alkali Syndrome)
09/2000
1
Hepatocellular Carcinoma (Hepatoma)
09/2000
1
Bone Resorption
09/2000
1
Liver Neoplasms (Liver Cancer)
01/2000
Drug/Important Bio-Agent (IBA)
3
Ghrelin
IBA
04/2006 - 07/2004
2
Chemokines
IBA
09/2013 - 02/2007
1
Cytokines
IBA
02/2022
1
Interleukin-6 (Interleukin 6)
IBA
09/2019
1
Mechanistic Target of Rapamycin Complex 1
IBA
12/2017
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
05/2016
1
Yohimbine (Yocon)
IBA
05/2016
1
Prazosin (Minipress)
FDA Link
Generic
05/2016
1
Phentolamine (Z-Max)
FDA Link
Generic
05/2016
1
Liraglutide
FDA Link
06/2014
1
ErbB Receptors (EGF Receptor)
IBA
09/2013
1
Ligands
IBA
09/2013
1
Phosphotransferases (Kinase)
IBA
09/2013
1
Messenger RNA (mRNA)
IBA
09/2013
1
Chemokine Receptors
IBA
09/2013
1
CCR7 Receptors
IBA
09/2013
1
oxidized low density lipoprotein
IBA
05/2009
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
05/2009
1
HDL Cholesterol
IBA
05/2009
1
Interleukin-8 (Interleukin 8)
IBA
02/2007
1
Interleukin-8A Receptors (Receptors, Interleukin 8A)
IBA
02/2007
1
Glucose (Dextrose)
FDA Link
Generic
04/2006
1
Growth Hormone (Somatotropin)
IBA
07/2004
1
Chitosan
IBA
05/2002
1
propagermanium (Ge 132)
IBA
06/2001
1
Polymers
IBA
06/2001
1
Acids
IBA
06/2001
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
06/2001
1
doxifluridine
IBA
03/2001
1
Proteins (Proteins, Gene)
FDA Link
01/2001
1
Estrogen Receptors
IBA
01/2001
1
Carcinoembryonic Antigen
IBA
01/2001
1
Platinum
IBA
12/2000
1
Docetaxel (Taxotere)
FDA Link
12/2000
1
Calcium
IBA
09/2000
1
Alendronate (Alendronate Sodium)
FDA Link
Generic
09/2000
1
Diphosphonates (Bisphosphonates)
IBA
09/2000
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2000
1
Cisplatin (Platino)
FDA Link
Generic
01/2000
Therapy/Procedure
1
Nerve Block (Nerve Blocks)
05/2016
1
Injections
05/2016
1
Sympathectomy (Sympathectomies)
09/2012
1
Renal Dialysis (Hemodialysis)
05/2009
1
Immunotherapy
03/2001
1
Radiotherapy
03/2001
1
Nephrectomy
01/2001
1
Aftercare (After-Treatment)
09/2000
1
Intravenous Infusions
01/2000
1
Therapeutics
01/2000
1
Drug Therapy (Chemotherapy)
01/2000
1
Thoracotomy
01/2000